CONET: a virtual human system-centered platform for drug discovery

References

[1] Harvey A L. Natural products in drug discovery. Drug Discovery Today, 2008, 13(19): 894–901

[2] Park B K, Boobis A, Clarke S, Goldring C E P, Jones D, Kenna J G, Lambert C, Laverty H G, Naisbitt D J, Nelson S, Nicoll-Griffith D A, Obach R S, Routledge P, Smith D A, Tweedie D J, Vermeulen N, Williams D P, Wilson I D, Baillie T A. Managing the challenge of chemically reactive metabolites in drug development. Nature Reviews Drug Discovery, 2011, 10(4): 292–306

[3] Nelander S, Wang W Q, Nilsson B, She Q B, Pratilas C, Rosen N, Gennemark P, Sander C. Models from experiments: combinatorial drug perturbations of cancer cells. Molecular Systems Biology, 2008, 4(1): 216

[4] Langley G R, Adcock I M, Busquet F, Crofton K M, Csernok E, Giese C, Heinonen T, Herrmann K, Hofmann-Apitius M, Landesmann B, Marshall L J, Mclvor E, Muotri A R, Noor F, Schutte K, Seidle T, Van de Stolpe A, Esch H V, Willett C, Woszczek G. Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations. Drug Discovery Today, 2016, 22(2): 327–339

[5] Hwang W, Hwang Y, Lee S, Lee D. Rule-based multi-scale simulation for drug effect pathway analysis. BMC Medical Informatics and Decision Making, 2013, 13(1): 1–9

[6] Yu H, Jung J, Yoon S, Kwon M, Bae S, Yim S, Lee J, Kim S, Kang Y, Lee D. CODA: integratingmulti-level context-oriented directed associations for analysis of drug effects. Scientific Reports, 2017, 7: 7519

RIGHTS & PERMISSIONS

2018 Higher Education Press and Springer-Verlag GmbH Germany, part of Springer Nature